Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®.
Sign Up to like & getrecommendations! Published in 2017 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2017.06.018
Abstract: BACKGROUND Fixed-dose combinations of inhaled corticosteroids and long-acting β2 agonists are commonly used for the treatment of asthma and COPD. However, the most frequently prescribed dry powder inhaler delivering this medicine - Symbicort® (budesonide and… read more here.
Keywords: turbuhaler; healthcare; inhalation technique; spiromax ... See more keywords
Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial
Sign Up to like & getrecommendations! Published in 2018 at "Respiration"
DOI: 10.1159/000493860
Abstract: Background: The fixed-dose combination of budesonide/formoterol (B/F) has been available in the Spiromax® dry powder inhaler since 2014. Objectives: To assess patient satisfaction, inhaler use errors, and disease control in patients with asthma or chronic… read more here.
Keywords: satisfaction; asthma chronic; inhaler; disease ... See more keywords